Aurelie Hatton

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

SPL84 and trikafta® exhibit comparable and additive effects in patient-derived HBE cells carrying the 3849+10kb C→T/F508del CFTR variants.

SPL84 and trikafta® exhibit comparable and additive effects in patient-derived HBE cells carrying the 3849+10kb C→T/F508del CFTR variants.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: March 14, 2026

Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR.

Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR.

Journal: Frontiers in pharmacology
Published: July 07, 2025

CFTR correctors potentiate gating mutants causing cystic fibrosis.

CFTR correctors potentiate gating mutants causing cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: May 14, 2025

TLN468 changes the pattern of tRNA used to read through premature termination codons in CFTR.

TLN468 changes the pattern of tRNA used to read through premature termination codons in CFTR.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: November 20, 2023

Putting bicarbonate on the spot: pharmacological insights for CFTR correction in the airway epithelium.

Putting bicarbonate on the spot: pharmacological insights for CFTR correction in the airway epithelium.

Journal: Frontiers in pharmacology
Published: September 13, 2023

Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells.

Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells.

Journal: Cell reports. Medicine
Published: July 26, 2023

Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis children.

Nonsense mutations accelerate lung disease and decrease survival of cystic fibrosis children.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: April 10, 2023

Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription.

Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription.

Journal: The European respiratory journal
Published: January 18, 2023

The U UGA C sequence provides a favorable context to ELX-02 induced CFTR readthrough.

The U UGA C sequence provides a favorable context to ELX-02 induced CFTR readthrough.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: July 02, 2022

Isolation, cultivation, and application of primary respiratory epithelial cells obtained by nasal brushing, polyp samples, or lung explants.

Isolation, cultivation, and application of primary respiratory epithelial cells obtained by nasal brushing, polyp samples, or lung explants.

Journal: STAR protocols
Published: June 06, 2022

Primary Human Nasal Epithelial Cells: Biobanking in the Context of Precision Medicine.

Primary Human Nasal Epithelial Cells: Biobanking in the Context of Precision Medicine.

Journal: Journal of visualized experiments : JoVE
Published: May 09, 2022

Reclassifying inconclusive diagnosis for cystic fibrosis with new generation sweat test.

Reclassifying inconclusive diagnosis for cystic fibrosis with new generation sweat test.

Journal: The European respiratory journal
Published: January 28, 2022
Showing 1-12 of 34

Last Updated: 09/26/2026